SCHEMBL14218062

SCHEMBL14218062

CCOc1ccc(Br)cc1/C=C/C(=O)N1CCN(CC)CC1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR183 P32249 7/20 0.61
TDP1 Q9NUW8 3/20 0.56
KMT2A Q03164 3/20 0.49
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 2/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
AR P10275 1/20 0.46
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
DUSP3 P51452 1/20 0.44
PTPN5 P54829 1/20 0.44
PTPN11 Q06124 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4378984 0.91 GPR183 (0.55) GPR183TDP1KDM4EHPGDTSHR
SCHEMBL14190909 0.91 GPR183 (0.55) GPR183TDP1KDM4EHPGDTSHR
SCHEMBL14190947 0.89 GPR183 (0.48) GPR183TDP1KMT2AMEN1HPGD
SCHEMBL4384367 0.89 GPR183 (0.48) GPR183TDP1KMT2AMEN1HPGD
SCHEMBL4381584 0.84 SMN1; SMN2 (0.47) GPR183TDP1KDM4EHPGDTSHR
SCHEMBL13636007 0.84 SMN1; SMN2 (0.47) GPR183TDP1KDM4EHPGDTSHR
SCHEMBL4381901 0.83 SMN1; SMN2 (0.46) GPR183KDM4EHPGDTSHRSMN1; SMN2
SCHEMBL14190929 0.83 SMN1; SMN2 (0.46) GPR183KDM4EHPGDTSHRSMN1; SMN2
SCHEMBL4380528 0.83 ALDH1A1 (0.48) GPR183KMT2AKDM4EHPGDTSHR
SCHEMBL13636356 0.83 ALDH1A1 (0.48) GPR183KMT2AKDM4EHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113968-A1 Substituted piperazines and diazepanes HRH3, HRH4, HRH1 GPR183 264/4885TDP1 3908/4885KMT2A 295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.